Dr. Robert Califf, commissioner of the U.S. Food & Drug Administration, discusses the promising research behind a new class of diabetes and obesity drugs that could improve tens of millions of lives in America impacted by the obesity epidemic.
He addresses the FDA’s pending new tobacco control rules, as well as improvements to the infant formula pipeline in the wake of recent shortages. Dr. Califf also voices deep concerns that health misinformation is the ‘leading cause of death in America now.’
Podcast: Play in new window | Download
Subscribe: Apple Podcasts | Spotify | Android | Podchaser | TuneIn | RSS | More
Originally broadcast October 2, 2025 The federal government is shut down and the ripple effects…
Originally broadcast Tuesday, September 23, 2025 Happy anniversary to “Conversations on Health Care”! We posted…
Dr. Wayne Jonas, who formerly led the National Institutes of Health Office of Alternative Medicine,…
Next week former Centers for Disease Control and Prevention Director Susan Monarez will testify in…
Supporters say Health and Human Services Secretary Robert F. Kennedy, Jr. is fulfilling his vision…
Originally broadcast Wednesday, August 27 Dr. Victor Montori, a Mayo Clinic endocrinologist, internationally recognized researcher,…